from AMA Corporation (EPA:ALAMA)
AMA : RAPPORT FINANCIER SEMESTRIEL 2024
KPMG S.A. 7 Boulevard Albert Einstein BP 41125 44311 Nantes Cedex 3 Téléphone : +33 (0)2 28 24 10 10 Télécopie : +33 (0)2 28 24 10 16 Site internet : www.kpmg.fr | AMA Corporation Immeuble Calypso 130 rue Eugène Pottier 35000 RENNES |
Nantes, le 30 octobre 2024
Rapport mission d’établissement des comptes consolidés
Conformément aux termes de notre lettre de mission en date du 4 décembre 2023, nous avons mis en œuvre les diligences que nous avions contractuellement définies :
L’objectif principal de notre mission est d’établir les états financiers consolidés de votre groupe pour le semestriel au 30 juin 2024. Elle comporte les étapes suivantes :
Une assistance à la mise en place du process de consolidation.
L’établissement des comptes consolidés proprement dits (bilan, compte de résultat, tableau de flux de trésorerie et annexes).
Ne réalisant pas de mission d’opinion sur les différentes sociétés du groupe, la responsabilité de la fiabilité de l’information financière reste exclue du champ d’application de cette mission.
Ils comportent 29 pages et se caractérisent par les données suivantes :
Montant des capitaux propres consolidés (part groupe) | 5 103 | KEUR |
Total du bilan | 12 342 | KEUR |
Chiffre d’affaires | 1 288 | KEUR |
Résultat net consolidé | (4 770) | KEUR |
Les travaux que nous avons mis en œuvre dans le cadre de cette mission ne constituent ni un audit, ni un examen limité ; en conséquence, nous n’exprimons pas d’opinion sur les comptes de votre entité qui sont joints au présent rapport.
KPMG SA
Aurélien Garel
Expert-comptable
KPMG Audit Ouest, société de commissaires aux comptes rattachée à la Compagnie régionale des commissaires aux comptes de Ouest Atlantique. Société française membre du réseau KPMG constitué de cabinets indépendants affiliés à KPMG International Limited, une société de droit anglais (« private company limited by guarantee »). | Société par actions simplifiée Siège social : 7 Boulevard Albert Einstein 44311 Nantes Cedex 3 Capital social : 200 000 € 512 802 547 RCS Nantes |
CONSOLIDATED INCOME STATEMENT
2024.06 |
€ 000 Notes2023.06
1 288 (310) 78 (1 815) (2 840) (468) (83) |
Revenue 7.11 664
Cost of sales 7.3(535)
Other income 7.2232
Other purchases and external expenses 7.3(1 319)
Personnel expenses 7.4.2.(3 407)
Amortisation and depreciation of property, plant and equipment and intangible assets 11.1 & 11.2(581)
Other expenses 7.3(114)
|
Non-current operating income Non-current operating expenses | 7.5 | (647) | |
Non-current operating loss | (647) |
-
Financial income | 8. | 128 | |
Financial expense | 8. | (91) | |
Net financial expense | 37 | ||
Loss before income tax | (4 759) |
52
(11) |
Loss for the year | (4 770) |
Income tax expense
Profit (loss) for the year:
(4 728) (42) |
Attributable to owners of the Group(4 079) Attributable to non-controlling interests(36)
Earnings per share
(0,09) |
(0,09) |
Basic earnings per share (in euros) 10(0,18)
Diluted earnings per share (in euros) 10(0,18)
CONSOLIDATED STATEMENT OF
COMPREHENSIVE INCOME
2024.06 |
€ 000 Notes2023.06
Attributable to:
(4 717) (42) |
Owners of the Group(4 098)
Non-controlling interests(37)
CONSOLIDATED BALANCE SHEET
2024.06 |
€ 0002023.12
Intangible assets | 11.1. | 6 |
Property, plant and equipment | 11.2. | 201 |
Right-of-use assets | 12. | 1 113 |
Financial assets | 13. | 169 |
Deferred tax assets | 52 | |
Non-current assets | 1 541 |
16
302
1 093 164
51
1 626
Inventories | 14. | 452 |
Research tax credit receivable | 15. | 173 |
Trade receivables and related accounts | 15. | 547 |
Other current assets | 15. | 393 |
Cash and cash equivalents | 16. | 9 237 |
Current assets | 10 802 |
495
129 676
437 9 390
11 126
Total assets | 12 342 | 12 753 |
Share capital Share premium and reserves Foreign currency translation reserve Retained earnings | 17.1 | 7 680 |
37 505 | ||
53 | ||
(40 136) | ||
Equity attributable to owners of the Group | 5 103 |
Non-controlling interests | 35 |
Total shareholders' equity | 5 138 |
Non-current loans and borrowings Lease liabilities Defined benefit liability Deferred tax liabilities | 19.2 12. & 19.2 | 1 893 |
707 | ||
100 | ||
1 | ||
Non-current liabilities | 2 701 |
7 680
37 505 47
574
132
2
2 859
Current tax liabilities Current loans and borrowings Lease liabilities Trade and other payables Contract liabilities (deferred income) Current provisions Other current liabilities | 19.2 12. & 19.2 20. 7.1 18. 20. | 2 |
577 | ||
424 | ||
1 015 | ||
1 223 | ||
483 | ||
779 | ||
Current liabilities | 4 504 |
Total liabilities | 7 205 |
Total shareholders' equity and liabilities | 12 342 |
12 753 |
1
700
529
807
1 308 11
CONSOLIDATED STATEMENT OF CHANGES IN
EQUITY
Equity attributable to owners of the Group
€ 000 Note
Balance at 1st Jan. 2023 | 3 207 | 34 161 | 69 | ( 31 759) | 5 679 | 117 | 5 796 | |
Profit (loss) for the year | ( 4 079) | ( 4 079) | ( 36) | ( 4 115) | ||||
Other comprehensive income | ( 17) | ( 3) | ( 20) | ( 1) | ( 21) | |||
Profit / (loss) and other comprehensive income | - | - | ( 17) | ( 4 081) | ( 4 098) | ( 37) | ( 4 135) | |
Capital increase | 17.1 | 4 473 | 3 351 | 7 824 | 7 824 | |||
Capital reduction allocated to Guillemot Brothers' shareholder loan | 3.1 | - | - | - | ||||
Decrease in non-controlling interests with no change in control | 5.2. | - | - | - | - | |||
Increase in non-controlling interests with no change in control | 5.2. | ( 4) | ( 4) | ( 1) | ( 6) | |||
Equity-settled share-based payments | 7.4. | 160 | 160 | - | 160 | |||
Total transactions with owners of the Group | 4 473 | 3 351 | - | 156 | 7 980 | ( 1) | 7 979 | |
- | - | |||||||
Shareholders' equity at 30 Jun. 2023 | 7 680 | 37 513 | 51 | ( 35 684) | 9 560 | 79 | 9 640 | |
Balance at 1st Jan. 2024 | 7 680 | 37 505 | 47 | ( 39 524) | 5 708 | 76 | 5 784 | |
Profit (loss) for the year | ( 4 728) | ( 4 728) | ( 42) | ( 4 770) | ||||
Other comprehensive income | 6 | 5 | 11 | 0 | 11 | |||
Profit / (loss) and other comprehensive income | - | - | 6 | ( 4 723) | ( 4 717) | ( 42) | ( 4 759) | |
Capital increase | - | - | - | - | ||||
Waiver of Guillemot Brothers's shareholder loan | 4 000 | 4 000 | 4 000 | |||||
Capital reduction allocated to Guillemot Brothers' shareholder loan | 3.1 | - | - | |||||
Decrease in non-controlling interests with no change in control | 5.2. | - | - | - | - | |||
Increase in non-controlling interests with no change in control | 5.2. | ( 0) | ( 0) | 1 | 1 | |||
Equity-settled share-based payments | 7.4. | 112 | 112 | - | 112 | |||
Total transactions with owners of the Group | - | - | - | 4 112 | 4 112 | 1 | 4 113 | |
Shareholders' equity at 30 Jun. 2024 | 7 680 | 37 505 | 53 | ( 40 136) | 5 103 | 35 | 5 138 |
CONSOLIDATED CASH FLOW STATEMENT
2024.06 |
€ 000 Notes
Loss for the year | (4 770) | |
Adjustments for: – Depreciation of right of use assets – Depreciation of property, plant and equipment – Amortisation of intangible assets | 12. 11. 11.2 | |
330 | ||
129 | ||
9 | ||
– Net financial expense | 8 | (37) |
– Loss or gain on sale of property, plant and equipment – Cost of share-based payment | 11.2 7.4.3 | (2) |
112 | ||
– Income tax expense / (income) | 9.1 | 11 |
– Restructuring provision – Other non-cash items | 18 | 481 |
(0) | ||
Total adjustments | 1 031 | |
Operating cash flow before change in working capital and income tax | (3 739) | |
Effect of changes in: – Inventories – Trade receivables and related accounts – Contract liabilities | 14. 15. 7.1 | |
44 | ||
117 | ||
(92) | ||
– Advances and downpayments | 20. | 10 |
– Trade payables and related accounts – Provisions and employee benefits | 20. | 219 |
(29) | ||
– Other receivables/current liabilities Total changes | 15 & 20 | 61 |
330 | ||
Operating cash flow before income tax paid | (3 409) | |
Income tax paid | (57) | |
Net cash used in operating activities | (3 466) | |
Acquisition of property, plant and equipment and intangible assets Disposals of property, plant and equipment and intangible assets | 11. 11. | (32) |
1 | ||
Capitalised development costs Investment grants (incl. Research tax credit offsetting capitalised costs) Acquisition of financial assets Disposal of financial assets Net interest received | 11. | - |
- | ||
(4) | ||
- | ||
120 | ||
Net cash provided by (used in) investing activities | 85 | |
Capital increase | 17. | - |
Proceeds from new loans and borrowings Repayment of loans and borrowings Payment of lease liabilities Acquisition of non-controlling interests | 19. 19. 12. 5.2. | 4 000 |
(382) | ||
(327) | ||
- | ||
Interest paid on loans and bank overdrafts Interest paid on lease liabilities | 19. 12. | (36) |
(24) | ||
Net cash provided by (used in) financing activities | 3 231 | |
(4 115) |
307 255 25 40 17 160 14 - (65) 751 |
(3 363) 175 285 (55) 28 41 6 (88) 391 |
(2 972) |
(79) |
(3 051) |
(30) (3) - - (14) |
54 |
11 |
19 |
7 824 - |
(368) |
(294) |
(6) (45) |
(12) |
7 099 |
4 066 |
8 603 (28) |
12 641 |
Cash and cash equivalents at January 1 | 9 390 |
Effect of movements in exchange rates on cash held | (2) |
Cash and cash equivalents at 30 Jun | 9 237 |
Net increase (decrease) in cash and cash equivalents (150)
NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS
1. Presentation of the Group
AMA Corporation Plc ("the Company") is domiciled in the United Kingdom. The Company’s registered office is located in London. The consolidated financial statements comprise those of the Company and its subsidiaries (together referred to as "the Group").
The Group is a software developer and systems integrator for collaborative work, providing advanced, highly-secure remote solutions for connected devices. The Group’s XpertEye suite provides augmented reality, dynamic workflow management, and dynamic online scheduling and planning. Combined with smart glasses or other camera sources (endoscope, microscope, dermatoscope, etc.), these innovative solutions enable experts and on-site technicians to share data and knowledge in real time, making remote support easier and more effective for users. They meet an increasing need for smart workplace transformation in companies seeking to boost productivity and competitiveness in a wide range of areas such as remote support, training, testing and healthcare.
These IFRS condensed consolidated interim financial statements for the 6-month period ending on June 30, 2024 have been approved by the Board of the Company on October 28, 2024.
2. Basis for preparation
2.1. Statement of compliance
These condensed consolidated interim financial statements for the 6-month period ending on June 30, 2024 have been prepared in accordance with IAS 34 "Interim Financial Reporting" as adopted by the European Union (EU) and should be read in conjunction with the latest Company’s annual financial statements for the year ending on December 31, 2024 of the Company (the "latest annual financial statements").
They do not include all the information required for a complete set of financial statements prepared under IFRS. They do, however, include selected notes explaining significant events and transactions in order to understand the changes in the Company's financial position and performance since the last annual financial statements.
The accounting policies used to prepare these unaudited interim condensed consolidated financial statements are identical to those applied by the Group as of December 31, 2023, except for:
• texts whose application is compulsory as from January 1, 2024;
• the specific provisions of IAS 34 used in the preparation of the interim financial statements.
The new texts that are mandatory as of January 1, 2024, are the following:
• Amendments to IAS 1 Presentation of Financial Statements – Classification of Liabilities as Current or Non-current, and Non-current Liabilities with Covenants;
• Amendments to IAS 7 Statement of Cash Flows and IFRS 7 Financial Instruments: Disclosures – Supplier Finance Agreements; and
• Amendments to IFRS 16 Leases: Lease Liability in a Sale and Leaseback.
The impact of these amendments is not significant.
The standards and interpretations not yet mandatory as of June 30, 2024 are the following:
• Amendments to IAS 21 The Effects of Changes in Foreign Exchange Rates – Lack of Exchangeability whose application is for annual reporting periods beginning on or after January 1, 2025 (not yet approved by the UE);
• Amendments to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments: Disclosures – Amendments to the Classification and Measurement of Financial Instruments, whose application is for annual reporting periods beginning on or after January 1, 2026 (not yet approved by the EU);
• Amendments to IFRS 1, IFRS 7, IFRS 9, IFRS 10 et IAS 7 as part of the annual improvement process , whose application is for annual reporting periods beginning on or after January 1, 2026 (not yet approved by the EU);
• IFRS 18 Presentation and Disclosure in Financial Statements, whose application is for annual reporting periods beginning on or after January 1, 2027 (not yet approved by the EU);
• IFRS 19 Subsidiaries without Public Accountability: Disclosures, whose application is for annual reporting periods beginning on or after January 1, 2027 (not yet approved by the EU).
These texts have not been early adopted. The expected impacts are not considered significant, except for IFRS 18, for which the Group has not completed its assessment to date.
2.2. Use of judgments and estimates
In preparing these condensed interim financial statements, management has made judgments and estimates that affect the application of the Company's accounting policies and the reported amounts of assets and liabilities, income and expenses. Actual values may differ from estimated values.
2.3. Functional and presentation currency
The consolidated financial statements are presented in euros, which is the Company’s functional currency. All amounts have been rounded to the nearest thousand, unless otherwise indicated.
2.4. Seasonality of operations
The Group is not subject to significant seasonal fluctuations. The Group activity is linked to the progress of our clients' projects, which are not connected to seasonal events but depend on the internal schedules of each client.
3. Significant events of the period
In 2024:
• In the first half 2024, AMA launched a global savings plan focused on scaling back its workforce by more 20 positions in France and 5 in other countries, with one non-priority commercial business units shut down in China and the management of the customers reassigned to the other subsidiaries. That’s the reason why, a restructuring provision of €481k has been recorded in the group financial statements.
• A shareholder loan was granted by Guillemot Brothers Ltd for €4,000k on June 3, 2024. The loan was later fully waived on June 4, 2024.
• On 31 January 2022, AMA granted stock options to employees with an exercise price of €2.03, a vesting period ending on 31January 2024, and an option exercise period extending until 30 January 2028. On January 8, 2024, the Board of Directors, acting in accordance with section 16.2 of the plan, ratified a revision of the stock options' pricing. This adjustment involved issuing new options to supersede the original ones, aimed at maintaining their motivational value by lowering the exercise price from €2.03 to €0.21. This revision affected 878,500 stock options, which accounted for 1.7% of AMA's share capital. The financial impact recognized in January 2024 under IFRS 2 for this revision is €94 k.
In 2023:
• AMA Corporation Plc has increased its shareholding in AMA Xperteye Inc of €3k.
• On 12 June 2023, AMA launched a capital increase on Euronext Growth of an amount of €7,999k.
• On 27 June 2023, AMA has completed its fund raising of €7,999k by issuing 30,769,230 new ordinary shares with a nominal value of £0.125, at the price of €0.26 per share. GUILLEMOT BROTHERS SAS subscribed to this capital increase in AMA Corporation Plc for a number of 30,682,640 new shares, increasing its stake in AMA from 34.38% before this capital increase to 72.15% after the transaction.
• On 24 March 2023, the company established a stock option plan that represented 5% of AMA's share capital at the time. These stock options had a six-year lifespan and were exercisable at a price of €0.35 two years after their issuance, contingent upon meeting a condition of ongoing employment.
• On 31 December 2023, AMA Corporation Plc waved part of its loan granted within the scope of the loan agreement dated January 1st, 2019 to AMA SA, amounting to €2,247k in order to improve the financial position of AMA SA for the fiscal year 2023.
• The provision for employment safeguard plans has been partially reversed for €27k, of which €18k was used. A provision of €8k has been maintained 31 December 2023 to cover the costs of employees leaving the Group in 2024.
4. Subsequent events
None.
5. Consolidation scope
5.1. Consolidation scope
The consolidated companies are as follows:
* AMA OEIL DE L’EXPERT CANADA is indirectly held through AMA SA.
5.2. Consolidation scope
The impact of changes in non-controlling interests, while retaining control, are recognized in equity as indicated below:
On January 24, 2024, AMA Corporation Plc's wholly-owned Italian subsidiary, AMA Xperteye S.R.L. Italy, underwent liquidation. This action was carried out as part of the group's restructuring strategy initiated in 2022 and had no notable impact on the Group's consolidated financial position.
As a reminder, in 2023, AMA Corporation Plc has increased its shareholding in AMA XPERTEYE Inc for €3k. This operation resulted in an 0,7% increase in its equity interests.
6. Segment information
The Group’s chief operating decision maker refers to the members of the Executive Committee and the Board of Directors.
The Group comprises ten distribution subsidiaries, covering three geographic areas corresponding to the following segments:
• Europe, which includes subsidiaries in France, Germany, the UK, Romania and Spain and which primarily invoice customers in Europe;
• North America, which includes subsidiaries in the United States and Canada and which primarily invoice customers in the North American area;
• Asia, which includes subsidiaries in Hong Kong, Shanghai and Japan and which primarily invoice customers in the Asia area.
The subsidiaries in each geographic area correspond to operating segments with similar economic characteristics.
All of the subsidiaries offer similar products and services but are strategically monitored by geographic area.
Information relating to each operating segment is presented below. Operating income and adjusted EBITDA for each segment are used to measure performance as management considers that this information is the most relevant for understanding the earnings of each segment compared with earnings from other entities. Adjusted EBITDA is defined as operating income plus depreciation, amortisation and impairment of property, plant and equipment and intangible assets, share-based payment expenses, and other non-current expenses/income.
The other items in the income statement, including financial income and expenses as well as taxes, are included within “Registered office, support functions and intragroup”.
The "Cost of Sales" in the income statement is equal to the sum of "Merchandise purchases" and "Change in inventories" (included in the Profit margin in the segment information table below) and "Inventory impairment" (excluded from the Profit margin).
920 | 295 | 72 | 0 | 1 287 |
(144) | (83) | (7) | (10) | (245) |
- | - | (36) | (64) | (99) |
(22) | - | (22) | ||
(0) | - | - | (13) | (13) |
754 | 211 | 29 | (87) | 908 |
- | - | 14 | 42 | 56 |
16 | 3 | 1 | 56 | 76 |
(237) | (181) | (181) | (1 215) | (1 814) |
(353) | (260) | (186) | (2 040) | (2 840) |
(121) | (37) | (24) | (272) | (454) |
(93) | 2 | (2) | 12 | (81) |
91 | 273 | 486 | (850) | - |
57 | 12 | 137 | (4 355) | (4 149) |
(21) | - | (119) | (508) | (647) |
- | - | - | - | - |
(21) | - | (119) | (508) | (647) |
121 | 37 | 24 | 286 | 468 |
21 | - | 119 | 508 | 647 |
112 | 112 | |||
178 | 48 | 161 | (3 958) | (3 570) |
Revenue
Cost of sales
Inventory changes
Partnership commissions
Leased 'Xperteye Amortisation and rental costs
Margin excluding in inventory depreciation
Reversal / Depreciation of inventory
Other income
Other purchases and external expenses
Personnel expenses
Other depreciation of property, plant and equipment and intangible assets
- Other non-current expenses/(income)
- Share-based payments
Adjusted EBITDA
1 274 | 255 | 130 | 5 | 1 664 |
(46) | (21) | (55) | (201) | (322) |
- | - | 13 | (249) | (236) |
(33) | - | (5) | - | (38) |
(1) | - | - | (47) | (48) |
1 195 | 234 | 82 | (491) | 1 020 |
- | - | (39) | 100 | 61 |
19 | 10 | 1 | 202 | 232 |
(270) | (196) | (198) | (654) | (1 319) |
(503) | (276) | (238) | (2 391) | (3 407) |
(114) | (35) | (35) | (349) | (533) |
(423) | 33 | (8) | 283 | (114) |
191 | 247 | 428 | (867) | - |
94 | 17 | (6) | (4 166) | (4 061) |
- | ||||
- | - | - | - | - |
- | - | - | - | - |
115 | 35 | 35 | 396 | 581 |
160 | 160 | |||
209 | 52 | 29 | (3 610) | (3 320) |
Revenue
Merchandise purchases
Inventory changes
Partnership commissions
Leased 'Xperteye Amortisation and rental costs
Margin excluding inventory depreciation
Reversal / Inventory impairment
Other income
Other purchases and external expenses
Personnel expenses
Other amortisation and depreciation of property, plant and equipment and intangible assets
- Share-based payments Other non-current expenses/income
*Reinvoicing between the AMA Corporation Plc parent company or AMA SA and distribution subsidiaries
In 2024, two major events had an impact on the EBITDA of the Group. The events have been restated in the “Adjusted EBITDA” to provide an accurate reflection of the Group’s financial performance. The following adjustments were made:
‐ Non-current expenses of €647k linked to the redundancy plan.
‐ The revision of the stock options' pricing, recognized in January 2024 under IFRS 2, has a financial impact of €94 k.
7. Operating data
7.1. Revenue
Revenue
Revenue is split as follows:
931 | 1 075 |
288 | 452 |
2 | 52 |
1 221 | 1 579 |
67 | 85 |
1 288 | 1 664 |
Software & support services
Equipment sales Pilot contracts
XpertEye solution revenue
Other services
The Group experienced a decline in turnover by 23% compared to the previous year.
Revenues linked to its core business, selling the XpertEye software suite, decreased to a lesser extent by 14%. While sales of equipment such as connected equipment, glasses, and smartphones dropped by 37%. These trends continue to reflect the wait-and-see approach observed for clients and prospects facing a deteriorating economic environment.
Contract liabilities
Changes in contract liabilities (prepaid income) is split as follows:
308 | 456 |
680 | 769 |
(765) | (839) |
223 | 386 |
Contract liabilities at 1 January
Increase in amounts received, net of revenue recognised for the period
Revenue recognised for the period included in opening amount
Contract liabilities at 30 June
7.2. Other income
Other income breaks down as follows:
On June 30, 2024, Other operating income mainly comprises the reversal of the €8k provision for employment safeguard plans and the reversal of the €14k for the depreciation of trade receivables.
On June 30,2023, Other operating income mainly comprises the reversal of the €73k provision for Google Pixel telephones (see Note 18) and the reversal of the €23k for the depreciation of trade receivables.
2024.06 2023.06
Operating grants | 47 |
Other operating income | 31 |
Total other operating income | 78 |
127
105
232
7.3. Operating expenses
Operating expenses break down as follows:
2024.06 2023.06
Equipment purchases | (245) | |
Change in inventories | (99) | |
Inventory impairment | 56 | |
Partnership commissions | (22) | |
Total cost of sales | (310) | |
Total employee benefits | 7.4.2. | (2 840) |
Non-stock purchases | (31) | |
Lease expenses | 12. | (24) |
General sub-contracts | (645) | |
Professional fees | (412) | |
Travel & entertainment | (142) | |
Trade fairs & marketing fees | (214) | |
Other | (345) | |
Total other purchases and external expenses | (1 815) | |
Total amortisation and depreciation of property, plant and equipment, intangible and right of use assets | 11. | (468) |
Taxes | (40) | |
Other | (43) | |
Total other expenses | (83) |
(322) (236)
61
(38)
(535)
(3 407)
(47)
(25) (291)
(260)
(240)
On June 30, 2024, the increase in “General sub-contracts” (€355k) is related to the increase in subcontracts of development in AMA SA.
The increase in "Professional fees" (€174k) is linked to the increase in legal and professional fees (€80k), legal audit accounting fees (€18k), accounting and other fees (€70k), and in financial communication fees (€6k).
The decrease in “Travel & entertainment” (€-98k) is linked to the decrease of sales and business in the subsidiaries.
The increase in “Other” caption, under Other purchases and external expenses (51 k€), mainly relates to Guillemot Brothers management fees (€64k), and postal fees (€-14k).
7.4. Personnel and headcount
7.4.1. Headcount
Managers | 2024.06 |
64 | |
Others employees | 12 |
Average headcount in the period | 76 |
2023.06
69
14
83
7.4.2. Personnel expenses
Personnel expenses break down as follows:
2024.06 | 2023.06 | |
Wages and salaries Post-employment defined contribution expenses Post-employment defined benefit expenses | (2 613) | (3 097) (145) (6) |
(145) | ||
29 | ||
Equity-settled share-based payments | (112) | (160) |
Total | (2 840) | (3 407) |
The decrease in personnel expenses mainly reflects the reduction in the number of employees (see Note 7.4.1).
7.4.3. Share-based payment
On June 30, 2023, AMA Corporation plc granted 2 233 000 stock options (SO) to employees and a corporate representative of AMA CORP, AMA SA, AMA US, AMA Germany, AMA Shanghai, AMA Srl, AMA Japan, AMA Italy and AMA UK. The vesting period is two years. The contractual term is on January 30, 2028 for the first plan of 1 115 500 stocks initiated in 2022 and on March 27, 2029 for the second plan of 1 120 500 stocks initiated in 2023.
On January 8, 2024, the Board of Directors, acting in accordance with section 16.2 of the first plan, ratified a revision of the stock options' pricing. This adjustment involved issuing new options to supersede the original ones, aimed at maintaining their motivational value by lowering the exercise price from €2.03 to €0.21. This revision affected 878,500 stock options, which accounted for 1.7% of AMA's share capital.
The fair value of the stock options was measured based on Black-Scholes model. The inputs used to measure the 2022 stock options fair value at grant date are as follows:
SO 2022 SO 2023
Fair value at grant date €0,11 €0,15 Share price at grant date €0,27 €0,35 Exercice price of the option €0,21 €0,35
Expected volatility (weighted average) 42,32% 53,00%
Expected life span 6 years 6 years
Maturity 4 years - mid-life 4 years - mid-life
Expected dividend - - Risk-free interest rate (based on government bonds) 2,68% 2,53%
0% for founders and directors 0% for founders and directors
Turnover rate 5% for managers 5% for managers
10% for employees 10% for employees
In 2024 and 2023, changes in the number of stock options were as follows:
30 Jun. 2024
Options number Options nb
SO 2022 SO 2023 Total
Outstanding as of January 1st, | 878 500 | 1 057 000 | 1 935 500 |
Lapsed during the period | - 1 112 500 | - 263 500 | - 1 376 000 |
Exercised during the period | - | ||
Granted during the period | 1 112 500 | 1 112 500 | |
Outstanding as of June 30, | 878 500 | 793 500 | 1 672 000 |
During the periods ended June 30, 2024, share-based payments of €112k were expensed and June 30, 2023, share-based payments of €160k were expensed.
7.5. Non-current operating income and expenses
On June 30 2024, Non-current operating expenses relates to the Group restructuring plan for €647k. It includes €508k for employment safeguard plans (including a provision for €481k) and €139k of termination benefits costs.
On June 30 2023, there are not non-current operation income and expenses.
8. Net financial income and expense
Group financial income and expense is split as follows:
€ 000 | 2024.06 | 2023.06 | |
Interest expense on loans | (60) | (53) | |
Foreign exchange losses | (24) | (28) | |
Other interest expense | (6) | (11) | |
Interest and related expenses | (91) | (92) |
8 120 128 |
Foreign exchange gains41 Other financial income11
Interest and related income52
On June 30, 2024, the “Other financial income” mainly comprises interest on bank savings (€29k) and cash equivalents income (€74k).
9. Taxation
The income tax expense is determined based on the pre-tax profit for the interim period multiplied by management's best estimate of the weighted average annual tax rate expected for the full year. This rate is adjusted for the tax effect of certain items fully recognized in the interim period. Accordingly, the effective tax rate in the interim financial statements may differ from management's estimate of the effective tax rate in the annual financial statements.
For the six-month period ending June 30, 2024, the Group's effective tax rate for continuing operations is 25% (for the six-month period ending June 30, 2023: 19%).
10. Earnings per share
Earnings per share takes into account the June 27th, 2023, operations during which capital increase of 30 769 230 shares.
Earnings attributable to holders of ordinary shares (basic):
2024.06 | 2023.06 | |
Net earnings attributable to owners of the Company | (4 079) | |
(4 728) | ||
Net earnings attributable to holders of ordinary shares | (4 728) | (4 079) |
Weighted average number of ordinary shares (basic and diluted): | 2023.06 | |
2024.06 | ||
Ordinary shares at 1 January | 53 225 045 | 22 455 815 |
Capital decrease Capital increase | 512 821 | |
Weighted average number of ordinary shares at 30 June | 53 225 045 | 22 968 636 |
Basic earnings per share in € | - 0,09 | - 0,18 |
Diluted earnings per share in € | - 0,09 | - 0,18 |
Weighted average number of ordinary shares at 30 June 2024 does not include the outstanding stock options.
Indeed, as the result of continuing operations is a loss, instruments giving deferred rights to capital such as stock options have an anti-dilutive effect. They are therefore not considered, and basic earnings per share are therefore identical to diluted earnings per share.
11. Intangible assets and property, plant and equipment
11.1. Intangible assets
Intangible assets are split as follows:
2024.06 |
€ 000 2023.12 Additions Disposals Amortisation for Effects of Reclassifications
the period changes in
foreign exchange rates
Development costs | 11 039 | - | - | - | - | 11 039 | ||||||
Software | 455 | - | (72) | - | - | 383 | ||||||
Intangible assets in progress | 1 328 | - | - | - | - | 1 328 | ||||||
Intangible assets (gross) | 12 823 | - | (72) | - | - | - | 12 750 | |||||
Amortisation of development costs | (11 039) | - | - | - | - | (11 039) | ||||||
Amortisation of software | (439) | 72 | (11) | - | - | (377) | ||||||
Amortisation of intangible assets in progress | (1 328) | - | - | - | - | (1 328) | ||||||
Amortisation/impairment of intangible assets | (12 806) | - | 72 | (11) | 0 | - | (12 745) | |||||
Total net value | 16 | - | - | (11) | 0 | - | 6 | |||||
Development costs | 11 039 | - | - | - | - | - | 11 039 | |||
Software | 448 | - | - | - | - | - | 448 | |||
Intangible assets in progress | 1 328 | - | - | - | - | - | 1 328 | |||
Intangible assets (gross) | 12 816 | - | - | - | - | - | 12 816 | |||
Amortisation of development costs | (11 039) | - | - | - | - | - | (11 039) | |||
Amortisation of software | (421) | - | - | (25) | - | - | (445) | |||
Amortisation of intangible assets in progress | (1 328) | - | - | - | - | - | (1 328) | |||
Amortisation/impairment of intangible assets | (12 788) | - | - | (25) | 0 | - | (12 813) |
11.2. Property, plant and equipment
Property, plant and equipment breaks down as follows:
2024.06 |
2023.12 Additions Disposals Depreciation for Effects of Reclassifications the period changes in
€ 000
foreign exchange rates
XpertEye equipment - rental use | 298 | 1 | (71) | - | - | - | 227 | |
XpertEye equipment - internal use Technical facilities, equipment and tooling | 567 184 | 13 0 | (30) (5) | - - | - 0 | - | 551 | |
178 | ||||||||
Transportation equipment | 19 | - | - | - | - | - | 19 | |
Computer equipment | 765 | 18 | (41) | - | 1 | - | 743 | |
Plant and equipment in progress | - | - | - | - | - | - | - | |
Advances and downpayments for a real estate project | - | - | - | - | - | - | - | |
Other property, plant and equipment | 204 | - | - | - | 1 | - | 204 | |
Property, plant and equipment (gross value) | 2 037 | 32 | (147) | - | 1 | - | 1 923 | |
Dep. XpertEye equipment - rental use | (279) | - | 71 | (13) | - | - | (221) | |
Dep. XpertEye equipment - internal use Dep. of technical facilities, equipment and tooling | (530) (202) | - - | 28 7 | (24) (6) | - (0) | - - | (526) | |
(201) | ||||||||
Dep. of transportation equipment | (19) | - | - | - | - | - | (19) | |
Dep. of computer equipment | (560) | - | 37 | (65) | (1) | - | (588) | |
Dep. of other PPE | (145) | - | - | (21) | (0) | - | (166) | |
Depreciation/impairment of property, plant and equipment | (1 735) | - | 143 | (129) | (1) | - | (1 722) | |
Total net value | 302 | 32 | (4) | (129) | 0 | - | 201 | |
2023.06 |
2022.12 Additions Disposals Depreciation for Effects of Reclassifications € 000 the period changes in foreign
XpertEye equipment - rental use | 990 | 11 | (86) | - | - | 47 | 961 | |
XpertEye equipment - internal use Technical facilities, equipment and tooling | 942 148 | 20 41 | (30) (5) | - - | - 0 | 99 9 | 1 031 | |
193 | ||||||||
Transportation equipment | 37 | - | (18) | - | - | - | 19 | |
Computer equipment | 1 091 | 88 | (62) | - | 3 | - | 1 120 | |
Advances and downpayments for a real estate project | 817 | 3 | (817) | - | - | - | 3 | |
Other property, plant and equipment | 378 | 45 | (7) | - | 2 | - | 418 | |
Property, plant and equipment (gross value) | 4 403 | 217 | (1 026) | - | 5 | 146 | 3 745 | |
Dep. XpertEye equipment - rental use | (718) | - | 61 | (151) | - | - | (807) | |
Dep. XpertEye equipment - internal use Dep. of technical facilities, equipment and tooling | (664) (134) | - - | 27 10 | (118) (6) | - (0) | - - | (755) | |
(131) | ||||||||
Dep. of transportation equipment | (37) | - | 18 | - | - | - | (19) | |
Dep. of computer equipment | (453) | - | 61 | (135) | (2) | - | (529) | |
Dep. of other PPE | (176) | - | 5 | (69) | (0) | - | (241) | |
Depreciation/impairment of property, plant and equipment | (2 182) | - | 181 | (478) | (2) | - | (2 481) | |
Total net value | 2 221 | 217 | (845) | (478) | 3 | 146 | 1 264 |
Other fixtures, fittings and equipment correspond to work done in AMA offices.
11.3. Impairment tests
During the year 2022, the Group’s market capitalization declined by more than 80% which constitutes an indication of impairment. To determine if the carrying amount of R&D at the end of June 2022 exceeded its recoverable amount, the company used the value-in-use method. The value in use method involves estimating the future cash flows that the R&D’s cash-generating unit (CGU) will generate over the useful life of 5 years. All assets of the Group being largely dependent, budgets realized and validated by the management for all the Group are the most relevant inputs for estimating the future discounted cash flow generated by this R&D’s CGU.
The comparison of this recoverable amount estimated under reasonable and supportable assumptions to the carrying amount of the Group’s net assets led to depreciate R&D capitalized costs for their total amount.
In 2024, the underlying assumptions used in 2022 are maintained, and the research & development costs are recognized in expenses.
12. Leases
In the course of its business, the Group leases premises and vehicles and accesses dedicated servers with a lease component.
Right-of-use assets break down as follows:
€ 000 | Land and buildings | Vehicles | Servers | Other | TOTAL | |
Balance at Dec. 31, 2022 | 331 | 75 | 614 | 4 | 1 024 | |
Depreciation for the period | (128) | (34) | (143) | (1) | (307) | |
Additions to right-of-use assets | 255 | 40 | 7 | - | 302 | |
Derecognition of right-of-use assets | (116) | (2) | (142) | - | (260) | |
Foreign currency gains (losses) | (6) | - | - | (0) | (6) | |
Balance at June 30, 2023 | 336 | 80 | 335 | 3 | 754 | |
Balance at Dec. 31, 2023 | 251 | 85 | 756 | 1 | 1 093 | |
Depreciation for the period | (131) | (37) | (161) | (1) | (330) | |
Additions to right-of-use assets | 58 | 74 | 352 | - | 483 | |
Derecognition of right-of-use assets | (63) | - | (70) | - | (133) | |
Foreign currency gains (losses) | (0) | - | - | 0 | (0) | |
Balance at June 30, 2024 | 114 | 122 | 877 | 0 | 1 113 |
The related impact on profit and loss and cash flow is as follows:
‐ Amounts recognised in net profit (loss)
2024.06 2023.06
€ 000 € 000
(12) |
(330) |
Interest on lease liabilities(11)
Depreciation charge(307)
The expense recognised for leases of low-value assets or leases for less than one year is not material.
‐ Amounts recognised under cash flows:
2024.06 2023.06
€ 000 € 000
420 |
Total cash outflows attributable to leases294
13. Financial assets
Financial assets break down as follows:
2024.06 |
€ 000 2023.12
Non-consolidated equity investments | 4 | 4 |
Other non-consolidated deposit - non-current | 112 | 112 |
Loans, guarantees and other receivables - non-current | 56 | 53 |
Financial assets | 172 | 168 |
(3) (3) |
Depreciation loans, guarantees and other receivables - non-current(4)
Depreciation of financial assets(4)
14. Inventories
€ 000 | 2024.06 | 2023.12 |
Gross amount | 821 | |
722 | ||
Impairment | (270) | (326) |
Net | 452 | 495 |
Inventories mainly comprise glasses and accessories.
In 2024, a €71k depreciation reversal was recorded on products depreciated in 2021 or 2022.
In 2023, a €64k depreciation reversal was recorded on products depreciated in 2021 or 2022 and sold essentially to brokers in 2023, as obsolete smartphones for example (€ 88 k).
Inventory is regularly reviewed to identify discontinued items or items that pose resale difficulties.
15. Trade and other receivables, other current assets
Trade receivables and other current assets break down as follows:
The decrease in trade and other receivables in proportional with the decrease of sales.
16. Cash and cash equivalents
|
17. Equity
17.1. Share capital
AMA Corporation Plc’s share capital breaks down as follows:
Shares capital | Share premium |
Shares capital Share
premium
2024.06 | 2023.12 | ||||
Nb of shares | € 000 | € 000 | Nb of shares | € 000 | € 000 |
Shares outstanding at 1 January Capital reduction Capital increase | 53 225 045 | 7 680 | 37 505 |
Shares outstanding at 31 December – fully paid | 53 225 045 | 7 680 | 37 505 |
22 455 815 3 207 34 161
30 769 230 4 473 3 343 53 225 045 7 680 37 505 The par value of ordinary shares is €0.144.
On 27 June 2023, AMA Corporation Plc completed an increase in capital of €7,824k, by issuing 30,769,230 new ordinary shares with a nominal value of £0.125, priced at €0.26 per share. This transaction resulted in a nominal capital injection of €4,473k and a share premium of €3,351k..
GUILLEMOT BROTHERS SAS subscribed to this capital increase in AMA Corporation Plc for a number of 30,682,640 new shares, increasing its stake in AMA from 34.38% before this capital increase to 72.15% after the transaction.
18. Provisions and contingent liabilities
In 2020, a €538k provision was recognised for the upcoming replacement of Google Pixel telephones purchased by clients. The XpertEye Advanced APK (Android Package Kit), developed in 2020 and slated for release in 2021, were not compatible with the Google Pixel currently embedded in the XpertEye Advanced solution, or compatibility would require overly costly development. This provision has been reversed during the past three years.
In 2022, a €35k provision was recognised for employment safeguard plans (termination benefits). This provision has been completely reversed at June 30, 2024.
In 2024, an additional provision was recognised for employment safeguard plans (€481k). The restructuring plans include termination benefits and personnel expenses.
19. Loans and borrowings
19.1. Main terms and conditions
The terms and conditions of current loans are as follows:
Nominal value |
750 900 400 600 2 000 |
4 650 5 000 2 750 2 500 1 500 |
11 750 |
16 400 |
BPI €750 thousand loan | EUR | Fixed rate | 2023 |
BPO €900 thousand loan | EUR | Fixed rate | 2023 |
CIC €400 thousand loan | EUR | Fixed rate | 2024 |
CREDIT COOP €600 thousand loan | EUR | Fixed rate | 2029 |
BPI France €2,000 thousand loan Other financial liabilities due within one year and accrued loan interest | EUR | Fixed rate | 2028 |
Total bank loans Arkea credit line | EUR | Floating rate | 2025 |
Société Générale credit line | EUR | Floating rate | 2027 |
Crédit Agricole credit line | EUR | Floating rate | Undetermined |
LCL credit line | EUR | Floating rate | Undetermined |
Total available credit lines | |||
Total |
Currency Annual nominal Year of
€ 000
interest rate maturity
75 43 | |
43 | 93 |
600 | 600 |
1 800 | 2 000 |
28 | 40 |
2024.06 | 2023.12 |
Carrying amount | Carrying amount |
2 470 - 2 852
Fixed rates range from 0% to 1.9%, while floating rates are EURIBOR 3M +3.587%.
19.2. Change in loans and borrowings distinguishing cash and non-cash flows
Changes to loans and borrowings and lease liabilities in 2024 and 2023 were as follows:
€ 000 | 2023.12 | Cash inflows from new debt | Cash flows Interest paid | Repayment of borrowings | Foreign exchange gains (losses) | Interest expense | Changes in non-cash flows Others | Impact of IFRS 16 - Leases | Reclass. | 2024.06 |
Bank loans Current account with Guillemot Brothers Ltd | 2 152 - | - - | - - | - - | - | (258) - | ||||
1 893 | ||||||||||
- | ||||||||||
Total non-current borrowings and financial liabilities | 2 152 | - | - | - | - | - | - | (258) | 1 893 | |
Non-current lease liabilities Bank loans Bonds Accrued loan interest Other financial liabilities due within one year Current account with Guillemot Brothers Ltd | 574 660 1 39 (0) | 483 - - - - | (60) | (420) (369) - (13) - | (1) - - 1 - | 60 | - - | 71 258 - - - | 707 | |
549 1 27 0 | ||||||||||
Total current borrowings and financial liabilities | 700 | - | (60) | (382) | 1 | 60 | - - | 258 | 577 | |
Current lease liabilities € 000 | 529 2022.12 | - C Cash inflows from new debt | ash flows Interest paid | (35) Repayment of borrowings | 1 Foreign exchange gains (losses) | Changes i Interest expense | n non-ca Others | - sh flows Impact of IFRS 16 - Leases | (71) Reclass. | 424 |
2023.06 | ||||||||||
Bank loans Current account with Guillemot Brothers Ltd | 2 813 - | - - | - - | - - | - | (371) - | ||||
2 443 - | ||||||||||
Total non-current borrowings and financial liabilitie | 2 813 | - | - | - | - | - | - - | (371) | 2 443 | |
Non-current lease liabilities Bank loans Bonds Accrued loan interest Other financial liabilities due within one year Current account with Guillemot Brothers Ltd | 444 639 5 47 (0) | 303 - - - - | (53) | (294) (360) (4) (8) - | (3) - - 0 - | 53 | (267) - | 17 371 - - - | 201 | |
649 1 40 (0) | ||||||||||
Total current borrowings and financial liabilities | 691 | - | (53) | (372) | 0 | 53 | - - | 371 | 690 | |
Current lease liabilities | 583 | - | - | (3) | (17) | 562 |
20. Trade accounts payable, other current liabilities
Trade payables and other current liabilities break down as follows:
2024.06 |
€ 0002023.12
015 667 106 - 6 |
Total trade payables 807
Staff and social security payables - current 654
Tax payables (excl. income tax) 90 Prepaid income (excl. client contracts)-
Other payables - current 11
|
The trades payables change, concerns mainly AMA SA with an increase of €147k and AMA Corporation Plc with an increase of €76k.
21. Financial instruments and risk management
21.1. Classification and fair value of financial instruments
2024.06 2023.12
Carrying amount | Fair value |
168 | 168 |
4 | 4 |
172 | 172 |
547 | 547 |
9 237 9 784 | 9 237 |
9 784 | |
9 956 | 9 956 |
1 893 1 839 | |
- 1 893 | - |
1 839 | |
707 | N/A |
577 593 | |
0 | 0 |
1 015 | 1 015 |
- 1 592 | - |
1 608 | |
424 | N/A |
3 485 | 3 448 |
Accounting Fair value level Carrying amount Fair value
€ 000
category
Loans and guarantees Amortised cost Level 2 - Note 2
Fair value
Non-consolidated equity investments Level 3 - Note 3
through P&L
Total non-current financial assets
Trade and other receivables Amortised cost Note 1 Cash and cash equivalents Amortised cost Note 1
Total current financial assets
Total assets
Bank loans and other financial liabilities Amortised cost Level 2 - Note 5 Current account with Guillemot Brothers Ltd Amortised cost Level 2 - Note 5
Total non-current financial liabilities
Non-current lease liabilities Amortised cost Level 2 - Note 4574 N/A
Bank loans and other financial liabilities Amortised cost Level 2 - Note 5700 719 Current account with Guillemot Brothers Ltd Amortised cost Level 2 - Note 5(0) (0)
Trade payables Amortised cost Note 1807 807
Bank overdraft Amortised cost Note 1
Total current financial liabilities
Current lease liabilities Amortised cost Level 2 - Note 4
Total liabilities
Note 1 - The carrying amount of current financial assets and liabilities is deemed to be approximately their fair value.
Note 2 - The difference between the carrying amount and fair value of loans and guarantees is deemed immaterial.
Note 3 - The fair value of unconsolidated equity investments is immaterial.
Note 4 - As allowed for under IFRS, the fair value of lease liabilities and their level in the fair value hierarchy is not presented.
Note 5 - The fair value of loans and borrowings was estimated using future cash flows discounted at a market rate.
22. Risk management
The Group is exposed to interest rate risk, credit risk and liquidity risk. The Group has not identified any significant changes in the identified risks compared to December 31, 2023.
23. Related-party transactions
Since July 12, 2022, Guillemot Brothers SAS is the Group’s parent company. The Group has not identified any significant changes in transactions with related parties, except for the waiver of Guillemot Brothers's shareholder loan, as explained in note 3.
24. Off-balance sheet commitments
The Group has not identified any significant changes in off-balance sheet commitments in the first half of 2021, 2022, 2023 and 2024 compared to December 31, 2023, December 31, 2022, December 31, 2021 and December 31, 2020.